In addition, the immunofluorescence assay indicated that NAC markedly abolished the formation of GFP-MAP1LC3B puncta in m-THPC-PDT-treated CRC cells (Fig. 4D, E). This evidence concerns the gene MAP1LC3B and colorectal carcinoma.